Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05417594
Title Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies (CERTIS1)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors AstraZeneca

ovarian cancer

prostate cancer

fallopian tube cancer

peritoneum cancer

high grade glioma

Her2-receptor negative breast cancer

pancreatic cancer



AZD9574 + Temozolomide

Age Groups: adult | senior
Covered Countries USA | ESP | DEU

Additional content available in CKB BOOST